Life sciences firm Danaher to buy Abcam in $5.7 bln deal
Danaher Corp has agreed to acquire protein consumables manufacturer Abcam Plc in a $5.7 billion all-cash deal, aiming to expand its product portfolio and offset sluggish demand from smaller biotech companies.